Evidence map›Paper›PMID 41833960›Full record

ArticleScientific reports2026

QRNN-GRU framework for automatic argument and annotation extraction in medical drug reviews.

Eman Altameem, Mohammed Alnuem, Sarah Albassam

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eman AltameemInformation Systems Department, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia. EAAltameem@imamu.edu.sa.
Mohammed AlnuemInformation Systems Department, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.
Sarah AlbassamInformation Systems Department, College of Computer and Information Sciences, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Argument annotation in medical drug reviews is a challenging task due to noisy user-generated content, domain-specific terminology, and subjective expressions of medication efficacy and adverse effects. While argument mining has been explored in this domain, the diversity of modeling architectures investigated remains narrower compared to more extensively studied NLP tasks. In this study, we investigate a sequential QRNN–GRU framework for identifying argumentative components in the medical datasets, aiming to explore a hybrid architecture that balances effective modeling of argumentative structures with computational efficiency for this domain. The proposed model employs QRNN layers to efficiently capture local temporal patterns, followed by GRU layers to model longer-range sequential dependencies. Firefly Optimization is utilized for hyperparameter tuning to improve training stability and convergence behavior. Experimental results on drug review dataset show that the proposed approach achieves an F1-score of 89.20% and an accuracy of 91.47%, outperforming selected baseline models under the evaluated setting. To further examine the generalizability, the model additionally evaluated on Abstract RCT benchmark dataset, where it achieves competitive comparative performance against established state-of-the-art methods. Although the model demonstrates consistent performance across two benchmark datasets, the analysis is limited to medical texts and does not include cross-domain evaluation.

Indexed as

Data MiningNatural Language ProcessingNeural Networks, ComputerAlgorithmsHumansArgument AnnotationFireflies OptimizationGated Recurrent UnitMedical DataQuasi Recurrent Neural Network

Identifiers

PMID41833960
PMCPMC13121630

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.